Crohn's Disease and Colitis Trial, Recruiting NCT05683730 Sponsor: Central Hospital, Nancy, France Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT05683730
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 65 years old
  • You have been diagnosed with Crohn's disease for at least 3 months
  • Your Crohn's disease is considered mild to moderate, confirmed by specific stool and symptom score tests (confirm with trial site)
  • Your Crohn's disease medication has not changed for at least 3 months
  • You are willing and able to follow an intermittent calorie restriction diet for 16 weeks
  • You are covered by a social security or health insurance plan (confirm with trial site)
  • You have been fully informed about the study and have signed a consent form

Who may not be able to join:

  • Your body mass index (BMI) is below 18.5, meaning you may be considered underweight
  • You have already lost more than 5% of your body weight in the past month, or more than 10% in the past 6 months
  • You have active wounds or sores in the anal or surrounding area
  • You have a stoma (a surgically created opening on the abdomen for waste to pass through)
  • You have an eating disorder such as anorexia or bulimia
  • You are pregnant, recently gave birth, or are currently breastfeeding
  • You are under 18 years old
  • You are an adult under a form of legal guardianship or protection
  • You are an adult who is unable to give informed consent
  • You are currently detained or under certain types of court-ordered psychiatric care (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: CARON Bénédicte, MD, CHRU of Nancy, Hepatogastroenterology Department

Phone: 0383155580

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
18 April 2023
Est. completion
1 July 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Intestinal inflammation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov